RESAPP HEALTH
ResApp is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease. We are creating easy to use, affordable, clinically-validated and regulatory-approved diagnostic tools that only require a smartphone. Our solutions are designed to be easily integrated into existing telehealth solutions and we are also working on apps to provide respiratory disease diagnosis and management directly to consumers and healthcare providers. ###Narhex Life Sciences Ltd has completed the acquisition of ResApp Diagnostics Pty Ltd and will now change its name to ResApp Health.###
RESAPP HEALTH
Industry:
Health Care Health Diagnostics Medical Device
Founded:
1990-01-01
Address:
Perth, Western Australia, Australia
Country:
Australia
Website Url:
http://www.resapphealth.com.au
Total Employee:
1+
Status:
Active
Contact:
+61862115099
Email Addresses:
[email protected]
Total Funding:
17.84 M USD
Technology used in webpage:
SPF Domain Not Resolving Amazon Google Apps For Business Person Schema Gravatar Profiles Amazon S3 CDN DMARC Amazon Oregon Region Zendesk
Similar Organizations
Ancora Heart
Ancora Heart is dedicated to helping people with heart failure feel better and live longer.
ANDHealth
ANDHealth is an integrated ecosystem for the development & commercialisation of evidence-based digital health products.
ArcScan
ArcScan is developing a unique set of ophthalmic diagnostic applications.
Australian Digital Health Agency
The Australian Digital Health Agency leads and develops Australia's digital health strategy.
BioMe Oxford
Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Catalyst Health Ventures
Catalyst Health Ventures is a Boston-based venture capital firm that invests in disruptive solutions for unmet healthcare needs
DermaDetect
AI based diagnosis & treatment of skin disorders
DJ HealthUnion Systems Corp
A provider of digital hospital solutions in China
ELENZA
ELENZA developed the electronic “AutoFocal” Intraocular Lens, giving patients clear and natural visibility over the full range of vision.
EndoSound
EndoSound develops a technology that enables endoscopic ultrasound.
Genetesis
Genetesis is a rapidly growing medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease
Immunostics
Immunostics offers a broad portfolio of diagnostics solutions.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Intelligent Fingerprinting
Intelligent Fingerprinting uses high-definition detection reagents to identify metabolite substances through fingerprint testing.
Ivantis
Ivantis is focused on developing an innovative treatment for glaucoma which includes eye drops, laser therapy, and surgery.
Ivoclar Vivadent
Ivoclar Vivadent is dedicated to advancing the practice of dentistry for both dentists and technicians.
Care to Translate
Care to Translate develops a digital healthcare translation tool
LifeBuddi
Mobile app and digital health ecosystem
Lumea
Lumea is a market leader in digital pathology solutions that improve patient care.
M-SCAN
M-SCAN is a medical device company that develops portable mobile ultrasound devices for pregnant mothers.
MEC Dynamics
MEC Dynamics is engaged in the development and manufacture of point-of-care diagnostic products.
DailyRounds
Flipboard + Clinical Cases Challenges for Doctors.
Medylink
Medylink has designs and develops a digital platform that allows general practitioners to coordinate their actions with specialists.
Nanovery
Nanovery is developing nanorobots to diagnose the world’s deadliest diseases.
NeuroEchos
NeuroEchos is an innovative medical device and intelligent diagnosis service provider.
Omeza
Omeza is a hospital and healthcare company that provides wound care, venous leg ulcers, omega 3, and innovation.
Otivio
A privately owned company based in Oslo, Norway.
Parker Isaac
Lab automation for digital pathology
PhotoniCare
PhotoniCare has developed a patented imaging platform technology that provides growth opportunities beyond otology.
Sense Biodetection
Sense Biodetection Limited is a molecular diagnostics company .
SepTec
SepTec is developing and commercializing a revolutionary sample-to-answer sepsis diagnostic device.
Stentys
Stentys is a Coronary artery bifurcation stenosis treatment developer.
Steth IO
Steth IO is a developer of a smartphone stethoscope used to offer real-time visualization to heart and lung sounds.
Tremitas
Tremitas is the developer of Tremipen, a measuring device for Parkinson and other tremor diseases.
Vasoptic Medical
We are developing a low-cost, easy-to-use, portable retinal imager designed to non-invasively capture physiological information.
Know Labs
Know Labs is a non-invasive diagnostic technology platform that uses radio waves to identify and measure molecules in the body.
Metaoptima
Metaoptima delivers digital healthcare solutions. It was started by a team of Simon Fraser University and University of British Columbia
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.resapphealth.com.au Semrush global rank: 3.09 M Semrush visits lastest month: 5.19 K
- Host name: s08ae.syd5.hostingplatform.net.au
- IP address: 43.250.142.136
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "ResApp Health"
ResApp Health - Crunchbase Company Profile & Funding
ResApp is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease. We are creating easy to use, affordable, clinically …See details»
ResApp Acquired by Pfizer - University of Queensland
Oct 11, 2022 · Global biopharmaceutical company Pfizer has acquired University of Queensland startup ResApp Health Limited for $179 million. ResApp, an ASX-listed company based in Brisbane, has developed simple and inexpensive …See details»
ResApp Health (acquired by Pfizer) Information - RocketReach
ResApp Health (acquired by Pfizer) is a Medical Equipment Manufacturing, Manufacturing General, and Health Care company located in Brisbane, Queensland with $847000 in revenue …See details»
Pfizer Acquires ResApp Health - Sleep Review
Dec 9, 2022 · Global biopharmaceutical company Pfizer acquired University of Queensland (UQ) startup ResApp Health Ltd for $179 million on Sept 26, 2022. ResApp’s SleepCheckRx …See details»
Proposed Acquisition of ResApp Health by Pfizer For personal use …
Apr 11, 2022 · T +61 7 3724 0035 E [email protected] W www.resapphealth.com.au clinically validated products include ResAppDx, a smartphone-based acute respiratory disease …See details»
ResApp Health Company Profile 2024: Valuation, Investors
Developer of smartphone applications intended to assist doctors and empower patients to diagnose and manage respiratory disease.See details»
ResApp Health - Craft
ResApp Health is a company developing digital healthcare solutions to assist doctors and enable patients to diagnose and manage respiratory disease. Its diagnostic tools can be used via a …See details»
ResApp Health: Pfizer to acquire Australian app that claims to
Apr 12, 2022 · Pharmaceutical juggernaut Pfizer has made a $100 million bid to acquire a Brisbane-based app company that claims it can screen users for COVID-19 by coughing into a …See details»
ResApp secures firm commitments to raise $5.5 million For …
T +61 7 3724 0035 E [email protected] W www.resapphealth.com.au SleepCheck, a smartphone application which allows consumers to self-assess their risk of sleep apnoea. Both …See details»
ResApp announces positive results for a new novel smartphone …
Brisbane, Australia, 22 March 2022 – ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of …See details»
Pfizer acquires ResApp Health for $179 million - Startup News
Oct 3, 2022 · ResApp Health Limited, an ASX-listed company that has its origins in Perth, has been acquired by American pharmaceutical giant Pfizer for $179 million. The company has …See details»
Proposed Acquisition of ResApp Health by Pfizer
Apr 10, 2022 · Brisbane, Australia, 11 April 2022 - ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management …See details»
ResApp shareholders approve $180m Pfizer takeover - Business …
Sep 8, 2022 · Global biopharmaceutical giant Pfizer will progress with its $180 million takeover of Brisbane-based telehealth company ResApp Health (ASX: RAP) after the target’s …See details»
Pfizer pays $179m for Brisbane company behind smartphone app …
Sep 28, 2022 · A Brisbane-based company that invented a smartphone app it says can diagnose COVID-19 and other respiratory illnesses by listening to someone cough has been purchased …See details»
ResApp Health : Increased Scheme Consideration from Pfizer
Brisbane, Australia, 14 June 2022 - ResApp Health Limited (ASX:RAP) (ResApp or the Company) refers to the Scheme Implementation Deed (SID) announced on 11 April 2022 between the …See details»
Pfizer makes bid for ResApp and its respiratory diagnosis apps
Apr 14, 2022 · Pfizer's Australian unit has tabled an offer to buy ResApp Health and its smartphone apps for the management and diagnosis of respiratory diseases in a deal that …See details»
Study shows efficacy of ResAppDx use with masks
Jul 22, 2022 · ResApp Health Limited (ASX: RAP) is a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease. ResApp’s …See details»
ResApp Health : Health Teams to launch ResAppDx on aged care …
Feb 15, 2022 · ResAppDx is ResApp's acute respiratory diagnostic test that uses machine-learning technology to analyse signatures in cough sounds to diagnose respiratory disease …See details»
ResApp Receives Positive Results from Prospective At-Home
Esults from its prospective, blinded at-home obstructive sleep apnoea study. ResApp’s algorithms, which analyse a person’s breathing and snoring sounds recorded using a smartphone placed …See details»
ResApp Health - Facebook
ResApp Health is now a subsidiary of Pfizer, Inc.See details»